A recent study reported that SLC3A2 influences osteosarcoma growth through the PI3K/AKt signalling pathway10 and this could be the case in BC as demonstrated by our finding that high levels of SLC3A2 protein is positively associated with PIK3CA expression. Here, PIK3CA is linked to breast cancer.